These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9566272)

  • 1. Thyroid parameters during therapy with zotepine in delusional depression. Preliminary results.
    König F; Hauger B; Barg T; Wolfersdorf M
    Neuropsychobiology; 1998; 37(2):88-90. PubMed ID: 9566272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of delusional depression: experience with combinations of antidepressants with the neuroleptics zotepine and haloperidol.
    Wolfersdorf M; König F; Straub R
    Neuropsychobiology; 1994; 29(4):189-93. PubMed ID: 7914009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.
    Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I
    Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Body weight increase: a side effect of zotepin (Nipolept)?].
    Wetterling T; Müssigbrodt H
    Nervenarzt; 1996 Mar; 67(3):256-61. PubMed ID: 8901286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain: side effect of atypical neuroleptics?
    Wetterling T; Müssigbrodt HE
    J Clin Psychopharmacol; 1999 Aug; 19(4):316-21. PubMed ID: 10440458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between thyroid and pineal responses to antidepressant treatment.
    Brown GM; Singer W; Joffe R
    Depression; 1996; 4(2):73-6. PubMed ID: 9160644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-limiting case of atypical neuroleptic malignant syndrome associated with zotepine.
    Hsu WC; Lin ST; Chen CC; Tsang HY; Huang MF
    J Clin Psychopharmacol; 2011 Oct; 31(5):667-9. PubMed ID: 21881455
    [No Abstract]   [Full Text] [Related]  

  • 8. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with the neuroleptic zotepine--first results.
    Haug HJ
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):35-7. PubMed ID: 2883679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zotepine, a neuroleptic drug with a bipolar therapeutic profile.
    Dieterle DM; Ackenheil M; Müller-Spahn F; Kapfhammer HP
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):52-7. PubMed ID: 2883683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol.
    Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
    Int Clin Psychopharmacol; 1992; 7(1):23-7. PubMed ID: 1352521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression.
    Price LH; Conwell Y; Nelson JC
    Am J Psychiatry; 1983 Mar; 140(3):318-22. PubMed ID: 6131612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three cases of alopecia areata induced by zotepine.
    Kubota T; Ishikura T; Jibiki I
    Acta Neurol (Napoli); 1993 Jun; 15(3):200-3. PubMed ID: 7901970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose zotepine in the maintenance treatment of schizophrenia.
    Fleischhacker WW; Stuppäck C; Barnas C; Unterweger B; Hinterhuber H
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):61-3. PubMed ID: 2883685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-life delusional depression: acute and long-term treatment.
    Meyers BS
    Int Psychogeriatr; 1995; 7 Suppl():113-24. PubMed ID: 8580387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome.
    Rao ML; Ruhrmann S; Retey B; Liappis N; Fuger J; Kraemer M; Kasper S; Möller HJ
    Pharmacopsychiatry; 1996 Sep; 29(5):180-6. PubMed ID: 8895943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convulsive seizures in schizophrenic patients induced by zotepine administration.
    Hori M; Suzuki T; Sasaki M; Shiraishi H; Koizumi J
    Jpn J Psychiatry Neurol; 1992 Mar; 46(1):161-7. PubMed ID: 1353125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide).
    Reinhardt W; Sauter V; Jockenhövel F; Kummer G; Uppenkamp M; Witzke O; Philipp T; Reinwein D; Mann K
    Exp Clin Endocrinol Diabetes; 1999; 107(3):177-82. PubMed ID: 10376442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
    Wetzel H; von Bardeleben U; Holsboer F; Benkert O
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():23-9. PubMed ID: 1683336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.